The US Women and PrEP Working Group is a coalition of women from leading AIDS and women’s health organizations. The coalition advocates for a coordinated national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection.